MoneyWorks4Me

Emmessar Biotech & Nutrition informs about disclosure

04 Sep 2023 Evaluate
In terms of Regulation 34 of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Emmessar Biotech & Nutrition has informed that Mathurakavi Srinivasa Raghavan Ayyangar, Chief Promoter, have acquired 5026 equity shares of the company between August 30 & August 31, 2023, through open market. It has enclosed the disclosure under Regulation, 29(2) of the SEBI (SAST) Regulation 2011.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..